MEDIA AND PRESS
Labcorp Acquires Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients
Transaction expands capacity and strengthens full-service testing portfolio.
A lot needs to happen to get a great idea to market. Devices need feasibility and pivotal studies, diagnostics require analytical and clinical validation. And, of course, you want it to happen as effectively, safely, economically and as urgently as possible. To help you get a product from concept through development, from testing through regulatory approval, with reliable data and documentation along the way, we are your source.
Across the world, we are supporting visionaries to accurately and safely bring new life-changing options to market.
This effort places a sharp focus on prioritizing the value of your product to drive all aspects of rational product development, registration and standards.
Our team is highly experienced and effective at managing every stage of the development cycle—preclinical, clinical, regulatory, and post-market. Read More
Increase asset visibility and start strategic conversations that kick-start partnering with the help of MarketPlace. One connection is made every month in our complementary innovative platform that connects asset developers with investors and partners. Learn More
Impact of upcoming regulatory requirements on combination product reporting. Read More